A Real Picture of Relmada Therapeutics Inc (RLMD) Stock: The Fundamentals
Truist lowered the price target for the Relmada Therapeutics Inc (NASDAQ:RLMD) stock from “a Buy” to “a Hold”. The rating was released on October 14, 2022, according to finviz. The research report from Goldman has downgraded the stock from Buy to Neutral, with a price target set at $8. The stock was downgraded by Oppenheimer, […]
A leader in the success game: Relmada Therapeutics Inc (RLMD) Stock
Truist lowered the price target for the Relmada Therapeutics Inc (NASDAQ:RLMD) stock from “a Buy” to “a Hold”. The rating was released on October 14, 2022, according to finviz. The research report from Goldman has downgraded the stock from Buy to Neutral, with a price target set at $8. The stock was downgraded by Oppenheimer, […]
